从政府控制转向市场主导:药品价格形成机制的新转变

发布时间：2018-01-19 15:36

本文关键词： 药品价格改革市场主导药品价格形成机制　出处：《中国卫生资源》2015年04期 　论文类型：期刊论文

【摘要】：国家发展和改革委员会等7部委发布《推进药品价格改革的意见》提示了此次药品价格改革是逐步建立以市场为主导的药品价格形成机制,最大限度减少政府对药品价格的直接干预;机制转变是此次药品价格改革的内涵;政府作为市场参与主体,利用采购机制、医保支付机制和谈判机制实施市场干预,并通过医疗行为和价格行为监管实施综合管控,实现了药品价格形成机制从政府控制向市场主导的转变,而这一转变有赖于医疗保险与医疗服务相关政策的协同才能实现其最大效能。
[Abstract]:The National Development and Reform Commission and other seven ministries and commissions have issued "opinions on promoting Drug Price Reform", suggesting that this drug price reform is gradually establishing a market-oriented drug price formation mechanism. Minimizing direct government intervention in drug prices; The change of mechanism is the connotation of the drug price reform; As the main body of market participation, the government makes use of purchasing mechanism, medical insurance payment mechanism and negotiation mechanism to implement market intervention, and implements comprehensive control through medical behavior and price behavior supervision. The mechanism of drug price formation has changed from government control to market leading, which depends on the coordination of medical insurance and medical service related policies to achieve its maximum effectiveness.
【作者单位】：复旦大学公共卫生学院健康风险预警治理协同创新中心;
【基金】：国家社科基金重大项目(11&ZD176)
【分类号】：F426.72
【正文快照】： 由国家发展和改革委员会等7部委发布的《推进药品价格改革的意见》再一次激发了社会各界于2014年11月《推进药品价格改革方案(征求意见稿)》下发以来的热议。为社会所普遍关心的是取消药品政府定价是否会造成药品价格大幅上涨以致病人经济负担的增加,是否会有利于廉价药品的有

【相似文献】